Beyond conflict of interest: maybe wrong questions are being askedBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7467.686-c (Published 16 September 2004) Cite this as: BMJ 2004;329:686
- Jon Drucker (email@example.com), medical librarian
- Wilmington, DE 19806, USA
EDITOR—Lenzer reports that scandals have eroded the US public's confidence in the drug industry.1 Although we should be shocked over the tangled fiduciary relations between the cholesterol guideline authors and Big Pharma, we should also examine how the underlying research was funded. Beyond the overt conflicts of interest among eight of nine authors …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial